Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
View/ Open
Date
2017-05-01Author
Phelan, CM
Kuchenbaecker, KB
Tyrer, JP
Kar, SP
Lawrenson, K
Winham, SJ
Dennis, J
Pirie, A
Riggan, MJ
Chornokur, G
Earp, MA
Lyra, PC
Lee, JM
Coetzee, S
Beesley, J
McGuffog, L
Soucy, P
Dicks, E
Lee, A
Barrowdale, D
Lecarpentier, J
Leslie, G
Aalfs, CM
Aben, KKH
Adams, M
Adlard, J
Andrulis, IL
Anton-Culver, H
Antonenkova, N
AOCS study group,
Aravantinos, G
Arnold, N
Arun, BK
Arver, B
Azzollini, J
Balmaña, J
Banerjee, SN
Barjhoux, L
Barkardottir, RB
Bean, Y
Beckmann, MW
Beeghly-Fadiel, A
Benitez, J
Bermisheva, M
Bernardini, MQ
Birrer, MJ
Bjorge, L
Black, A
Blankstein, K
Blok, MJ
Bodelon, C
Bogdanova, N
Bojesen, A
Bonanni, B
Borg, Å
Bradbury, AR
Brenton, JD
Brewer, C
Brinton, L
Broberg, P
Brooks-Wilson, A
Bruinsma, F
Brunet, J
Buecher, B
Butzow, R
Buys, SS
Caldes, T
Caligo, MA
Campbell, I
Cannioto, R
Carney, ME
Cescon, T
Chan, SB
Chang-Claude, J
Chanock, S
Chen, XQ
Chiew, Y-E
Chiquette, J
Chung, WK
Claes, KBM
Conner, T
Cook, LS
Cook, J
Cramer, DW
Cunningham, JM
D'Aloisio, AA
Daly, MB
Damiola, F
Damirovna, SD
Dansonka-Mieszkowska, A
Dao, F
Davidson, R
DeFazio, A
Delnatte, C
Doheny, KF
Diez, O
Ding, YC
Doherty, JA
Domchek, SM
Dorfling, CM
Dörk, T
Dossus, L
Duran, M
Dürst, M
Dworniczak, B
Eccles, D
Edwards, T
Eeles, R
Eilber, U
Ejlertsen, B
Ekici, AB
Ellis, S
Elvira, M
EMBRACE Study,
Eng, KH
Engel, C
Evans, DG
Fasching, PA
Ferguson, S
Ferrer, SF
Flanagan, JM
Fogarty, ZC
Fortner, RT
Fostira, F
Foulkes, WD
Fountzilas, G
Fridley, BL
Friebel, TM
Friedman, E
Frost, D
Ganz, PA
Garber, J
García, MJ
Garcia-Barberan, V
Gehrig, A
GEMO Study Collaborators,
Gentry-Maharaj, A
Gerdes, A-M
Giles, GG
Glasspool, R
Glendon, G
Godwin, AK
Goldgar, DE
Goranova, T
Gore, M
Greene, MH
Gronwald, J
Gruber, S
Hahnen, E
Haiman, CA
Håkansson, N
Hamann, U
Hansen, TVO
Harrington, PA
Harris, HR
Hauke, J
HEBON Study,
Hein, A
Henderson, A
Hildebrandt, MAT
Hillemanns, P
Hodgson, S
Høgdall, CK
Høgdall, E
Hogervorst, FBL
Holland, H
Hooning, MJ
Hosking, K
Huang, R-Y
Hulick, PJ
Hung, J
Hunter, DJ
Huntsman, DG
Huzarski, T
Imyanitov, EN
Isaacs, C
Iversen, ES
Izatt, L
Izquierdo, A
Jakubowska, A
James, P
Janavicius, R
Jernetz, M
Jensen, A
Jensen, UB
John, EM
Johnatty, S
Jones, ME
Kannisto, P
Karlan, BY
Karnezis, A
Kast, K
KConFab Investigators,
Kennedy, CJ
Khusnutdinova, E
Kiemeney, LA
Kiiski, JI
Kim, S-W
Kjaer, SK
Köbel, M
Kopperud, RK
Kruse, TA
Kupryjanczyk, J
Kwong, A
Laitman, Y
Lambrechts, D
Larrañaga, N
Larson, MC
Lazaro, C
Le, ND
Le Marchand, L
Lee, JW
Lele, SB
Leminen, A
Leroux, D
Lester, J
Lesueur, F
Levine, DA
Liang, D
Liebrich, C
Lilyquist, J
Lipworth, L
Lissowska, J
Lu, KH
Lubinński, J
Luccarini, C
Lundvall, L
Mai, PL
Mendoza-Fandiño, G
Manoukian, S
Massuger, LFAG
May, T
Mazoyer, S
McAlpine, JN
McGuire, V
McLaughlin, JR
McNeish, I
Meijers-Heijboer, H
Meindl, A
Menon, U
Mensenkamp, AR
Merritt, MA
Milne, RL
Mitchell, G
Modugno, F
Moes-Sosnowska, J
Moffitt, M
Montagna, M
Moysich, KB
Mulligan, AM
Musinsky, J
Nathanson, KL
Nedergaard, L
Ness, RB
Neuhausen, SL
Nevanlinna, H
Niederacher, D
Nussbaum, RL
Odunsi, K
Olah, E
Olopade, OI
Olsson, H
Olswold, C
O'Malley, DM
Ong, K-R
Onland-Moret, NC
OPAL study group,
Orr, N
Orsulic, S
Osorio, A
Palli, D
Papi, L
Park-Simon, T-W
Paul, J
Pearce, CL
Pedersen, IS
Peeters, PHM
Peissel, B
Peixoto, A
Pejovic, T
Pelttari, LM
Permuth, JB
Peterlongo, P
Pezzani, L
Pfeiler, G
Phillips, K-A
Piedmonte, M
Pike, MC
Piskorz, AM
Poblete, SR
Pocza, T
Poole, EM
Poppe, B
Porteous, ME
Prieur, F
Prokofyeva, D
Pugh, E
Pujana, MA
Pujol, P
Radice, P
Rantala, J
Rappaport-Fuerhauser, C
Rennert, G
Rhiem, K
Rice, P
Richardson, A
Robson, M
Rodriguez, GC
Rodríguez-Antona, C
Romm, J
Rookus, MA
Rossing, MA
Rothstein, JH
Rudolph, A
Runnebaum, IB
Salvesen, HB
Sandler, DP
Schoemaker, MJ
Senter, L
Setiawan, VW
Severi, G
Sharma, P
Shelford, T
Siddiqui, N
Side, LE
Sieh, W
Singer, CF
Sobol, H
Song, H
Southey, MC
Spurdle, AB
Stadler, Z
Steinemann, D
Stoppa-Lyonnet, D
Sucheston-Campbell, LE
Sukiennicki, G
Sutphen, R
Sutter, C
Swerdlow, AJ
Szabo, CI
Szafron, L
Tan, YY
Taylor, JA
Tea, M-K
Teixeira, MR
Teo, S-H
Terry, KL
Thompson, PJ
Thomsen, LCV
Thull, DL
Tihomirova, L
Tinker, AV
Tischkowitz, M
Tognazzo, S
Toland, AE
Tone, A
Trabert, B
Travis, RC
Trichopoulou, A
Tung, N
Tworoger, SS
van Altena, AM
Van Den Berg, D
van der Hout, AH
van der Luijt, RB
Van Heetvelde, M
Van Nieuwenhuysen, E
van Rensburg, EJ
Vanderstichele, A
Varon-Mateeva, R
Vega, A
Edwards, DV
Vergote, I
Vierkant, RA
Vijai, J
Vratimos, A
Walker, L
Walsh, C
Wand, D
Wang-Gohrke, S
Wappenschmidt, B
Webb, PM
Weinberg, CR
Weitzel, JN
Wentzensen, N
Whittemore, AS
Wijnen, JT
Wilkens, LR
Wolk, A
Woo, M
Wu, X
Wu, AH
Yang, H
Yannoukakos, D
Ziogas, A
Zorn, KK
Narod, SA
Easton, DF
Amos, CI
Schildkraut, JM
Ramus, SJ
Ottini, L
Goodman, MT
Park, SK
Kelemen, LE
Risch, HA
Thomassen, M
Offit, K
Simard, J
Schmutzler, RK
Hazelett, D
Monteiro, AN
Couch, FJ
Berchuck, A
Chenevix-Trench, G
Goode, EL
Sellers, TA
Gayther, SA
Antoniou, AC
Pharoah, PDP
Type
Journal Article
Metadata
Show full item recordAbstract
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.
Subject
AOCS study group
EMBRACE Study
GEMO Study Collaborators
HEBON Study
KConFab Investigators
OPAL study group
Humans
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Genetic Predisposition to Disease
Telomere-Binding Proteins
BRCA1 Protein
BRCA2 Protein
Risk Factors
Genotype
Mutation
Polymorphism, Single Nucleotide
Alleles
Female
Meta-Analysis as Topic
Genome-Wide Association Study
Genetic Loci
Carcinoma, Ovarian Epithelial
Research team
Complex Trait Genetics
Aetiological Epidemiology
Oncogenetics
Language
eng
Date accepted
2017-03-03
License start date
2017-05
Citation
Nature genetics, 2017, 49 (5), pp. 680 - 691
Publisher
NATURE PORTFOLIO
Related items
Showing items related by title, author, creator and subject.
-
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher, FR; Al Olama, AA; Berndt, SI; Benlloch, S; Ahmed, M; et al. (NATURE PORTFOLIO, 2018-07-01)Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 ... -
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
Saunders, EJ; Dadaev, T; Leongamornlert, DA; Al Olama, AA; Benlloch, S; et al. (SPRINGERNATURE, 2016-04-12)BACKGROUND: Germline mutations within DNA-repair genes are implicated in susceptibility to multiple forms of cancer. For prostate cancer (PrCa), rare mutations in BRCA2 and BRCA1 give rise to moderately elevated risk, ... -
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang, V; Geybels, MS; Jordahl, KM; Gerke, T; Hamid, A; et al. (WILEY, 2021-07-01)BACKGROUND: Inflammation and one of its mediators, NF-kappa B (NFκB), have been implicated in prostate cancer carcinogenesis. We assessed whether germline polymorphisms associated with NFκB are associated with the risk of ...